Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Seizures”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Testing effectiveness (Phase 2)Study completedNCT00871377
What this trial is testing

Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures

Who this might be right for
Epilepsy
National Center for Complementary and Integrative Health (NCCIH) 24
Not applicableLooking for participantsNCT05845255
What this trial is testing

Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data

Who this might be right for
Quality of LifeEpilepsy (treatment Refractory)
MJN Neuroserveis, S.L 130
Large-scale testing (Phase 3)Study completedNCT03014752
What this trial is testing

Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy

Who this might be right for
Epilepsy Intractable
Tehran University of Medical Sciences 50
Not applicableStudy completedNCT01281293
What this trial is testing

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Who this might be right for
Epilepsy
Cyberonics, Inc. 124
Large-scale testing (Phase 3)Study completedNCT01586208
What this trial is testing

Refractory Status Epilepticus Treatment Study

Who this might be right for
Grand Mal Status EpilepticusNon-convulsive Status Epilepticus
Hospital Universitari de Bellvitge 5
Large-scale testing (Phase 3)Study completedNCT00957684
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Refractory Partial Epilepsy
Bial - Portela C S.A. 402
Large-scale testing (Phase 3)Study completedNCT01618695
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Who this might be right for
Partial-onset Seizures
Eisai Co., Ltd. 940
Not applicableEnded earlyNCT03790436
What this trial is testing

Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

Who this might be right for
EpilepsyEpilepsy IntractableSeizures+3 more
University of Southern California 10
Not applicableStudy completedNCT00071305
What this trial is testing

Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 35
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableStudy completedNCT01796574
What this trial is testing

Ketogenic Diet for Refractory Status Epilepticus

Who this might be right for
Status EpilepticusSeizureEpilepsy+2 more
Johns Hopkins University 15
Testing effectiveness (Phase 2)Study completedNCT00048490
What this trial is testing

Transcranial Magnetic Stimulation to Treat Epilepsy

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 70
Not applicableEnded earlyNCT02560597
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy

Who this might be right for
Epilepsia Partialis ContinuaStatus Epilepticus
University Hospital, Ghent 4
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Testing effectiveness (Phase 2)Study completedNCT02052739
What this trial is testing

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

Who this might be right for
Super-refractory Status Epilepticus
Supernus Pharmaceuticals, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00152451
What this trial is testing

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB S.A. - Pharma Sector 31
Not applicableEnrolling By InvitationNCT06952764
What this trial is testing

Epilepsy Cycles Longitudinal Monitoring to Inform Personalized Seizure-risk Estimation (ECLIPSE)

Who this might be right for
Epilepsy (Treatment Refractory)
Insel Gruppe AG, University Hospital Bern 14
Testing effectiveness (Phase 2)Study completedNCT00236730
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 178
Large-scale testing (Phase 3)Study completedNCT00772603
What this trial is testing

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 366
Post-approval studies (Phase 4)Ended earlyNCT01266291
What this trial is testing

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Who this might be right for
Complex Partial Seizures
University of Pennsylvania 1
Load More Results